| Mrs Erica Lee Lyons, MS, CF-SLP | |
|
17700 W Capitol Dr, Brookfield, WI 53045-2006 | |
| (262) 781-3083 | |
| (262) 781-3080 |
| Full Name | Mrs Erica Lee Lyons |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 17700 W Capitol Dr, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023248689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3185-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Erica Lee Lyons, MS, CF-SLP 2323 N 90th St, Wauwatosa, WI 53226-1828 Ph: (920) 242-6395 | Mrs Erica Lee Lyons, MS, CF-SLP 17700 W Capitol Dr, Brookfield, WI 53045-2006 Ph: (262) 781-3083 |
News Archive
Often called the most devastating epidemic in the recorded history of the world, the 1918 influenza virus pandemic was responsible for more than 40 million deaths across the globe.
In the first study of its kind, researchers at Saint Louis University are recruiting patients for a clinical trial that will use cutting-edge imaging equipment to map the brain injuries of combat veterans and civilians, aiming to better understand the nature of their injuries.
In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).
While it is established that nicotine by itself is not carcinogenic, researchers have now shown that nicotine promotes cell proliferation and the progression of tumors already initiated by tobacco carcinogens.
› Verified 8 days ago
Katie Elizabeth Gubbins, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3360 Gateway Rd, Brookfield, WI 53045 Phone: 414-339-5542 | |
Kate Jablonski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 | |
Mrs. Sandra K Merkel, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 N Barker Rd, Brookfield, WI 53045 Phone: 262-391-5314 | |
Madeleine Elizabeth Fitzgerald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Patrick Blvd Ste 250, Brookfield, WI 53045 Phone: 888-754-0398 | |
Amy Unger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 | |
Lindy Marie Frechette, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3360 Gateway Rd Ste 100, Brookfield, WI 53045 Phone: 262-295-6289 |